BNET Industries
Market Cap:$403.4M
Last Fiscal Year Sales:$97.0M
- Public
- US
Dow Jones Description
SurModics is a leading provider of drug delivery and surface modification technologies to the healthcare industry. In November 2008, we announced a change in our organizational structure into four clinically and market focused business units: Cardiovascular, Ophthalmology, In Vitro Technologies, and SurModics Pharmaceuticals (formerly Brookwood Pharmaceuticals). We believe that this structure will improve the visibility, marketing and adoption of the Companys broad array of technologies within specific markets and help our customers in the medical device, pharmaceutical and life science industries better solve unmet clinical needs. In addition, a new centralized research and development function has been formed to serve the needs of the Companys clinically and market focused business units. SurModics Pharmaceuticals research and development operations remained unchanged. The reorganization change announced in November 2008 resulted in the Company being comprised of new operating segments. ...
Number of Employees 254
Peer Companies
NAICS Code Lessors of Nonfinancial Intangible Assets (except Copyrighted Works): 533110
Recent Events
-
Developments for Parkinson's Disease Ignite Investor Enthusiasm
-
SurModics signs license agreement with NuPathe for long-acting delivery (LADTM) technology
-
Barrington Research Downgrades SurModics SRDX to Market Perform
-
SurModics enters license and development agreement with Roche and Genentech
-
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
-
Genentech inks licensing deal with SurModics
-
SurModics inks $200M licensing deal with Genetech
-
SRDX: License and Development Agreement with Roche and Genentech
-
UPDATE 1-Church & Dwight settles with Abbott Labs, SurModics
-
SurModics Reports Third Quarter 2009 Results
News & Analysis
Filter by
earnings and surmodics inc. - All News and Analysis
SurModics, Inc.Q4 2009 Earnings Call Transcript
Seeking Alpha
- 2009-11-04
Question-and-Answer SessionOperator Operator Instructions Your first question comes from Richard Rinkoff with Craig-Hallum Group. Richard Rinkoff - Craig-Hallum Group I want to clarify something; did you say that you received $1.25 million in basically back payments from Abbott in the fourth quarter? Philip Ankeny Yes, essentially....
SurModics Inc. F2Q09 (Qtr End 03/31/09) Earnings Call Transcript
Seeking Alpha
- 2009-04-30
Question-and-Answer SessionOperator Operator instructions Our first question is from the line of Rick Rinkoff with Craig-Hallum. Rick Rinkoff – Craig-Hallum Well, congratulations on a better quarter than one before that. I had a couple of questions here, first of all you said the R&D includes a little bit of...
SurModics, Inc. F1Q09 (Qtr End 12/31/08) Earnings Call Transcript
Seeking Alpha
- 2009-01-28
Question-and-Answer SessionOperator Thank you, sir. Ladies and gentlemen we will now begin the question-and-answer session. Operator instructions. Our first question comes from the line of Ross Taylor with C.L. King, please go ahead. Ross Taylor – C.L. King & Associates, Inc. Hi. I got a couple of questions. First,...
SurModics, Inc. F4Q08 (Qtr End 09/30/08) Earnings Call Transcript
Seeking Alpha
- 2008-11-24
Question-and-Answer SessionOperator Operator instructions And our first question comes from the line of Ross Taylor with C.L. King; please go ahead. Ross Taylor – C.L. King Hi, I’ve got a couple of questions. I’ll try to keep them brief. First of all, why did the Abbott revenues dropped so...
- 1
Glass Door
| Company | Employer Rating |
| Alcoa |  |
| CBS Corp |  |
| Johnson & Johnson | |
| Costco Wholesale |  |
|
IndustryTop Rated
- Google Offers Free Downloads of a Million Books 11 votes
- InsideView Disrupts Legacy Business Info Publishers Like Hoover's 9 votes
- Mobile is the New Mass Medium, For Better or Worse 8 votes
- As Income Mobility Falls, American Dream Fades 7 votes
- Flat World Knowledge: A Disruptive Business Model 6 votes
